Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» July 2010
July 2010
FDA warning linked to Cubist drug
FDA warning linked to Cubist drug
Bizjournals.com
FDA
Cubist Pharmaceuticals
antibiotics
Cubicin
Merck profit drops 51%, adjusted net income rises
Merck profit drops 51%, adjusted net income rises
Marketwatch
Merck
earnings
Sanofi-Aventis to Genzyme: Game On
Sanofi-Aventis to Genzyme: Game On
Seeking Alpha
Sanofi
Genzyme
M&A
AstraZeneca
Charles River, WuXi Make Mutual Decision To End Deal
Charles River, WuXi Make Mutual Decision To End Deal
WSJ Online
Charles River Laboratories
WuXi PharmaTech
M&A
Amgen Q2 Beats, Driven by International Sales
Amgen Q2 Beats, Driven by International Sales
Barron's
Amgen
earnings
Is Abbott a Buy?
Is Abbott a Buy?
Motley Fool
Abbott Laboratories
Humira
Solvay
Neurocrine Looks Well Positioned
Neurocrine Looks Well Positioned
Yahoo/AP
Neurocrine
Abbott Laboratories
GSK
GnRH antagonists
Hospira plans big study for new Epogen biosimilar
Hospira plans big study for new Epogen biosimilar
Fierce Biotech
Hospira
Epogen
biosimilars
generics
anemia
Forget Respect -- Dendreon Needs Sales!
Forget Respect -- Dendreon Needs Sales!
Motley Fool
Dendreon
Provenge
prostate cancer
Sanofi To Send 'Bear Hug' Letter Within 72 Hours
Sanofi To Send 'Bear Hug' Letter Within 72 Hours
CNBC
M&A
Sanofi
Genzyme
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »